The rating affirmation is based on a number of factors, including Erlanger’s strong volume and revenue growth.
The outlook is positive, reflecting Moody’s Investors Service’s belief that Erlanger’s favorable revenue trajectory will translate into improved cash flow and liquidity.
More articles on healthcare finance:
Plexis Healthcare Systems to showcase payer platform
Iowa family planning clinic to close, executive director blames Medicaid privatization
Kindred to close Texas hospital, leaving 92 without jobs
